Introducing BioLehti, our CBD sister company!

At Hakala Research, we believe that the human body is strong and has the amazing power to heal itself, provided that it has the proper tools.  As a company, we routinely look for a natural option to healing versus a pharmaceutical band aid, masking the true issue.  The human body has receptor sites for the element Iodine, and research indicates that Iodine has beneficial effects on almost every organ and tissue. Over the course of time, Iodine has been depleted from our diets and become less available, leaving our bodies vulnerable.  When Iodine is not available, our bodies become deficient, inviting toxins to steal the open Iodine binding sites, which hampers optimal health.

Similar to our work with Iodine, we have been researching and discovering the benefits of Cannabidiol (CBD) for some time.  CBD, hemp oil extract, is a natural product from the cannabis sativa plant. Misclassified by the FDA for decades, the human population has been prevented from exploring, understanding, and utilizing CBD for health benefits.  Increasingly, it is difficult to ignore the science behind this natural healer. 

A cannabis plant is a complex group of hundreds of compounds.  More than 60 of these compounds are found only in the cannabis plant.  These are known as cannabinoids and they occur in varying levels in every plant. CBD is one primary cannabinoid that appears in high concentration in the hemp plant, it has a broad spectrum of medical benefits and has been proven highly therapeutic.  Given that CBD hemp oil extract contains less then 0.3% of THC, it has no toxic level known to science.  Additionally, it has a plethora of medicinal uses and benefits to the body.

Humans (and many animals) have cannabinoid receptors and an endocannabinoid system that processes cannabinoids.  The endocannabinoid system (ECS) is one of the body’s largest neurotransmitter networks but was only discovered fairly recently.  In 1990, medical scientists at the National Institute of Mental Health detailed the cannabinoid receptor system which led to finding the endocannabinoid system or ECS in 1992.

The ECS is always working to achieve balance (homeostasis), which means maintaining a stable internal environment despite changes in the external environment.  The ECS functions as a balancing system sending neurotransmitters (messenger and communication molecules) to all your bodily parts to check that everything is working smoothly and confirming if anything needs to be rebalanced. When it finds any issues, it regulates these by sending further instructions to receptors that adjust how you feel and think. The brain naturally produces endocannabinoid molecules, which act as messengers and can be found in the brain, organs, connective tissues, glands, and immune cells.  The ECS performs a unique mode of cell-to-cell communication that inhibits immune response, reduces inflammation, relaxes muscles, lowers blood pressure, and normalizes stimulated nerves. The ECS is crucial to proper functioning and health. Dysregulation of the ECS contributes to a wide variety of conditions that prevent the body from achieving balance.  Whether caused by an overproduction of an enzyme or protein or an overexpression of receptors, when the ECS isn’t functioning optimally your body has a difficult time regulating emotions, appetite, memory, and everything else the ECS is responsible for.

Cannabinoids look for and activate the two known cannabinoid receptors (CB1 and CB2) in the ECS system to tell your body to feel a certain way and do certain things. They also affect and regulate the way other bodily systems function, like your immune, nervous, and gastrointestinal systems.  Cannabinoid Receptor 1 (CB1) receptors are mainly located in the brain and nervous system, as well as in the lungs, liver, and kidneys. Our natural endocannabinoids and the cannabinoid THC from cannabis mainly bind with CB1 (due to their similar molecular structure), which gives patients relief from pain, nausea, depression, and other symptoms.  Cannabinoid Receptor 2 (CB2) receptors are found mainly in the immune system, with a heavy concentration in the spleen and in the gastrointestinal system. CB2 receptors bind best with the endocannabinoid 2-AG and cannabis’ CBD and are involved in the regulation of appetite, immune system functions like inflammation, and pain management.

The body’s best-known endocannabinoid, anandamide, does more than just make you feel blissful, it is synthesized in parts of the brain that are important for: memory, motivation, higher thought processes, movement, as well as pain, appetite, and fertility.

Cannabinoids from cannabis products can and do interact with cannabinoid receptors – but the receptors were not created for cannabis. They were created as part of the ECS to receive endocannabinoids (and the messages they send) from your brain. Interestingly enough, these receptors also far outnumber any other receptor found in the brain.  The ECS is just being supplemented when a person consumes CBD products and their receptors are stimulated. Thankfully, this means that many deficiencies and over expressions of certain characteristics of disease can be redirected by plant-based cannabinoids like CBD.

The best way to imagine cannabinoids and their receptors is like a lock and key. When a person consumes cannabis, the cannabinoids (keys) flood your body in search of receptors (locks).  When they find one that fits, the effects of the cannabinoid and the function and location of the receptor click together and messages are sent through the rest of your body. Beyond affinity for binding with certain molecules, receptors are also located in different body parts and have different density and numbers, which is considered to be the expression of the receptors.  The expression of receptors is as unique person-to-person as their fingerprints: everybody has a different balance, number, and concentration of them, which is why experimenting with cannabis medication is such a delicate and slow process. Different expressions of cannabinoid receptors mean different experiences consuming the same type of cannabis products.

The result of our research has led us to believe that CBD products have a strong place in medicine.  This is why we proudly introduce our sister company, BioLehti. The founders of BioLehti have been operating a compounding pharmacy for nearly 40 years and have been at the forefront of Iodine related research for over 30. As we age, we have been searching for products to help our friends and ourselves address the various issues that come with aging, ailments, and activity.  We create products to match the human body’s natural systems. With a nod to our Scandinavian roots, BioLehti is the merging of bio science and natural systems. In Finnish, Lehti can be loosely translated to leaf. Turning a corner, we are dedicated to exploring new fields to create products for your optimal health and well being. 

Similar to what you expect from Hakala Research, BioLehti will deliver the same dependable products and service.  Our CBD products are formulated from the best and most pure source ingredients, contain no THC, and are comprised of pure CBD without harsh additives or chemicals unnecessary for formulation.  Visit www.biolehti.com today and discover a new branch of natural healing.

 

Products available created by BioLehti:

The Phoenix - a chewable tablet in multiple strengths: 6.25mg, 12.5mg, 25mg

Flourish Cream - a topical cream, applied to the skin and rapidly absorbed.

Flourish Lotion - a more viscous version of the cream

 

Sources:

https://www.greenrelief.ca/blog/cannabinoid-receptors/

 

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.